Your browser doesn't support javascript.
loading
Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer.
Zhang, Xin; Wang, Xuemei; Hou, Lijian; Xu, Zheng; Liu, Yu'e; Wang, Xueju.
Affiliation
  • Zhang X; Department of Pathology, China-Japan Union Hospital, Jilin University, Changchun, China.
  • Wang X; Department of Pathology, China-Japan Union Hospital, Jilin University, Changchun, China.
  • Hou L; Department of Pathology, China-Japan Union Hospital, Jilin University, Changchun, China.
  • Xu Z; Department of Pathology, China-Japan Union Hospital, Jilin University, Changchun, China.
  • Liu Y; School of Medicine, Tongji University Cancer Center, Shanghai Tenth People's Hospital of Tongji University, Tongji University, Shanghai, China.
  • Wang X; Department of Pathology, China-Japan Union Hospital, Jilin University, Changchun, China.
Front Pharmacol ; 14: 1130937, 2023.
Article in En | MEDLINE | ID: mdl-37033636

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2023 Document type: Article Affiliation country: China Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2023 Document type: Article Affiliation country: China Country of publication: Switzerland